Post-Market Review of Products Used for Diabetes Management

To ensure sufficient time is available to facilitate input from all stakeholders, the Department has extended the due date for submissions toThursday, 15 November 2012.

The Pharmaceutical Benefits Advisory Committee (PBAC) has commissioned a Review of products and medicines used for diabetes management. The first stage of the Review is now open for submissions. Further information is available on the Reviews page of the PBS website, including the Terms of Reference for the Review.